Skip to main content

Month: August 2023

How Will the Proteomics Market Transform Itself into a USD 120.61 Billion Powerhouse by 2032?

Significant investments in discovery of biomarkers in proteomics is a key factor driving Proteomics market revenue growth. Vancouver, Aug. 15, 2023 (GLOBE NEWSWIRE) — Emergen research is one of the pioneers in providing strategic insights for emerging and disruptive technologies which are supposed to show exponential growth in the near future., has released a report that delves deep into the dynamic landscape of the Proteomics Market. In the rapidly evolving landscape of life sciences and medical research, the latest research analysis from Proteomics Insights presents a transformative paradigm set to redefine strategies within the Proteomics Market. Proteomics Insights refers to the pivotal practice of harnessing cutting-edge technologies and data analysis to unlock profound revelations, enabling informed decisions and the optimization...

Continue reading

Halvårsrapport for 1. halvår 2023 fra Totalbanken A/S

Totalbanken opnåede i 1. halvår 2023 et resultat før skat på 69,9 mio. kr. mod 30,2 mio. kr. i samme periode året før. Resultatet forrenter egenkapitalen med 22,1 pct. p.a. Bestyrelsen udtrykker stor tilfredshed med resultatet. – Totalbanken leverer et rekordresultat i 1. halvår 2023, konstaterer bankens direktør Ivan Sløk og fortsætter: Rekordresultatet er udtryk for, at de seneste års strategiske indsatser i koncernen – fx vækst på kundesiden – har givet udbytte, og at der samfundsøkonomisk har været medvind på de fleste cykelstier. Den 23. maj blev det offentliggjort, at Totalbanken og Sparekassen Danmark ønsker at fusionere med Sparekassen Danmark som det fortsættende institut. Fusionen er indstillet til vedtagelse på en ekstraordinær generalforsamling i Totalbanken den 30. august 2023 og på et repræsentantskabsmøde i Sparekassen...

Continue reading

Mainz Biomed Announces Financial Half Year Results 2023 and Provides Corporate Update

ColoAlert® Revenue Increases 108% Year Over Year in the First Six Months of 2023 ColoFuture and eAArly Detect Studies on Track to Report Results in September and in Q4, 2023 BERKELEY, Calif. and MAINZ, Germany, Aug. 15, 2023 (GLOBE NEWSWIRE) — Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the early detection of cancer, announced today the results of the first six months and second quarter ending June 30, 2023 and provided a corporate update. Key Highlights During Q2 2023ColoAlert® revenues for the first six months of 2023 were USD $499,049, representing an increase of 108% compared to the first half of 2022. Expanded international commercialization for ColoAlert®, a highly efficacious and easy-to-use DNA-based detection test for colorectal cancer (CRC)...

Continue reading

Interim Financial Report, first half of 2023

Jyske Realkredit A/S – Interim Financial Report, first half of 2023 To NASDAQ Copenhagen A/S                                                                                                                  15 August 2023                                                                                                                 Announcement No. 77/2023 Interim Financial Report, first half of 2023 On August 15, 2023, the Supervisory Board has approved the Interim Financial Report, first half of 2023 of Jyske Realkredit A/S. Please see attached file. Yours sincerely,Jyske Realkredit A/S Carsten Tirsbæk MadsenCEO Direct phone (+45) 89 89 90 50E-mail: ctm@jyskerealkredit.dk Web: jyskerealkredit.dk Please observe that the Danish version of this announcement prevails. Attached files:Interim Financial Report of Jyske Realkredit, Q2 2023.pdf...

Continue reading

Interim Financial Report H1 2023

Earnings per share rose 53% to DKK 37.5 (H1 2022: DKK 24.5)Net interest income rose 74% to DKK 4,639m (H1 2022: DKK 2,671m)Core income increased 57% to DKK 6,573m (H1 2022: DKK 4,197m)Core expenses rose 27% to DKK 2,974m (H1 2022: DKK 2,344m)Core profit before loan impairment charges increased 94% to DKK 3,599m (H1 2022: DKK 1,853m)Loan impairment charges amounted to an expense of DKK 109m (H1 2022: an income of DKK 247m)The net profit was up 47% to DKK 2,488m (H1 2022: DKK 1,691m)Capital ratio at 20.3%, of this common equity tier 1 capital ratio at 16.1% (H1 2022: 22.2% and 17.9%, respectively)For 2023, earnings per share is expected at DKK 70-80The integration of Handelsbanken Denmark is proceeding according to planThe acquisition of PFA Bank A/S is expected to close during the coming months.Summary ”...

Continue reading

Q2 2023 INTERIM REPORT – OUTLOOK RAISED

ANNOUNCEMENT NO. 28/2023Q2 performance better than expected Result below Q2 2022 due to temporary boost of Channel earnings in Q2 2022 Logistics acquisitions performing well EBITDA outlook raised to DKK 4.8-5.2bn (DKK 4.5-5.0bn) on 14 August 2023Q2 2023EBITDA decreased 5% to DKK 1.4bn Adjusted free cash flow DKK 601m NIBD reduced 4% from Q1 2023 CO2 emissions 8% lower per GT nautical mileOUTLOOK 2023EBITDA raised to DKK 4.8-5.2bn Revenue around same level as 2022 Investments of DKK 1.6bn“We have raised our outlook as we continued to deliver strong operational performance in Q2, and despite headwind in some regions, we achieved a result that was better than expected,” says Torben Carlsen, CEO.KEY FIGURES                        2023 2022   2022-23 2021-22   2022DKK m Q2 Q2 Change, % LTM LTM Change, % Full-year               Revenue 6,942 7,170 -3 27,148 23,102 18 26,873Operating...

Continue reading

FLSmidth & Co. Group Interim Report for Q2 2023: Strong momentum on key transformation efforts, positively impacting both operational and financial performance in Q2 2023

COMPANY ANNOUNCEMENT NO. 15-2023 15 August 2023, Copenhagen, DenmarkHighlights in Q2 2023Mining revenue growth of 23% mainly driven by Service Adjusted Mining EBITA margin improved to 10.8% Morse Rubber acquired to strengthen mill liner business Non-Core Activities order backlog reduced to DKK 1.4bn 33% decline in Cement order intake due to a slow-down in market demand Good cash flow generation Financial guidance for 2023 was raised on 8 August 2023Group CEO, Mikko Keto, commented: “We have maintained the strong momentum on our key transformation efforts during Q2 2023. While we have continued to progress on our MissionZero agenda, our safety performance has been unsatisfactory and mitigating actions have been taken. Our Mining business has seen good revenue growth and continued improvement in underlying profitability in a relatively...

Continue reading

Robust growth in Q2 – revenue guidance raised

Financial highlightsBrand strength and strong product offering combine to deliver robust growth. Q2 2023 organic growth accelerates to 5%, comprising of LFL (like-for-like) growth of +2% and network expansion of +4%. LFL growth in key markets in Europe broadly stable at 0%, US sees improvement to -4% LFL growth and Rest of Pandora sees ongoing strong growth at +12% LFL. Gross margins continue upward trend witnessed over past years and reach 78.1%, +170bp vs. Q2 2022. As expected, EBIT margin at 20.2% was -190bp Y/Y reflecting a.o. cost phasing and planned investments into growth. Full-year EBIT margin to be broadly in line with last year. Leverage remains low with NIBD/EBITDA at 1.3x. DKK 3.3 billion worth of shares purchased since February 8,  making good progress towards purchasing a total of DKK 5.0 billion by February 2, 2024...

Continue reading

Inside information: Aspocomp starts change negotiations on possible temporary layoffs at its Oulu plant

  Aspocomp Group Plc, Inside Information, August 15, 2023, at 8:50 a.m. Aspocomp starts change negotiations on possible temporary layoffs at its Oulu plant in Finland. Today, on August 15, 2023, Aspocomp has issued a negotiation proposal in accordance with the Act on Cooperation to start change negotiations for production-related and financial reasons at its Oulu plant. The majority of the Oulu plant’s approximately 120 production blue-collar employees are covered by the negotiations. The change negotiations are estimated to last two weeks, and the possible temporary layoffs would last a maximum of 90 days. With the change negotiations, the company prepares for a possible partial adjustment of production to correspond to temporarily low delivery volumes. Slower-than-expected recovery of the semiconductor cycle and high inventory levels...

Continue reading

JULY VOLUMES: FREIGHT CLOSING IN ON LAST YEAR, PASSENGERS UP 9%

INVESTOR NEWS no. 29 – 15 August Ferry – freight: Total volumes in July 2023 were 7.2% below 2022. Volumes were 4.9% below 2022 adjusted for Channel. North Sea volumes were robust on most routes but a slowdown in Swedish imports and a dip in fresh produce volumes to the UK due to weather conditions reduced overall volumes compared to 2022. Mediterranean’s volumes were below last year as growth is being reduced by measures to curb inflation in Türkiye and European demand is stagnating. Channel volumes were below 2022 which reflects the redistribution of market shares that took place in July 2022 in the wake of a ferry competitor’s suspension of sailings in 2022. Baltic Sea market conditions are starting to become more comparable to 2022 as the war’s impact on volumes did not fully materialise in 2022 until after the summer....

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.